Clinical and hematological parameters associated with omalizumab response in chronic spontaneous urticaria.

Xolair (omalizumab) - Roche, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42704614

Dursun Turkmen; Hacer Vural Karatoprak; Mehmet Enes Güner; Nihal Altunisik; Serpil Sener; Tuba Vural; Zekiye Kanat

Sep 8, 2026